The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 42 | — | 20.1x | Near average | |
Growth | 31 | 49.9% | 5.6% | Below average | |
Quality | 93 | 71.0% | 7.6% | Above average | |
Safety | 40 | 0.7x | 0.4x | Near average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | 94 | — | — | Above average | |
Sentiment | 35 | — | — | Near average |
Sutro Biopharma, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Sutro Biopharma, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
STRO stock has seen a gradual improvement in its average price target over the last 30 days, with the consensus rising from 50 to 51.8 dollars, representing a 3.6% increase. This rise was supported by new positive coverage from Barclays with an (Overweight) rating and a reaffirmation of an (Outperform) rating from Wedbush, reflecting growing optimism despite the recent exit of one analyst from coverage, which reduced the number of analysts to 6.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.